- Effects of Angiotensin II on ZO-1 in Glomerular Epithelial Cells
-
Koo HH, Ha TS
- KMID: 2307207
- Korean J Nephrol.
- 2007 Sep;26(5):516-525.
PURPOSE: Angiotensin II plays a potent role in renal injury not only by vasoconstrictive effects but also by biochemical effects. We investigated the effect of angiotensin II on ZO-1 (zonular... -
- CITED
-
- Close
- SHARE
-
- Close
- Association Analysis of a Polymorphism of the Angiotensin I-Converting Enzyme Gene and Angiotensin II Type 1 Receptor Gene in Korean Population
-
Yang YM
- KMID: 1538081
- J Genet Med.
- 1998 Mar;2(1):27-30.
Previously, we made a study report on the genotype disturbution and the gene frequency of angiotensin I-converting enzyme (ACE) in Korean population, and on the association between hypertension and genetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Angiotensin II type 1 receptor antibodies in kidney transplantation
-
Lee H, Oh EJ
- KMID: 2442597
- J Korean Soc Transplant.
- 2019 Mar;33(1):6-12.
- doi: 10.4285/jkstn.2019.33.1.6
Angiotensin II type 1 receptor (AT1R) antibodies directly injure endothelial and vascular smooth muscle cells by activating transcription factors associated with proinflammatory responses. Previous studies have shown that AT1R antibodies... -
- CITED
-
- Close
- SHARE
-
- Close
- Renovascular Hypertension and Nephrotic Range Proteinuria Developed after the Renal Artery Ligation: Successful Treatment by Combination of ACE Inhibitor and Angiotensin II Type 1 Receptor Blocker
-
Oh SW, Kim SC, Cha JJ, Kim MG, Woo YS, Boo CS, Jo SK, Cho WY, Kim HK
- KMID: 1465944
- Korean J Nephrol.
- 2009 May;28(3):230-235.
A 27-year-old woman presented with severe hypertension and nephrotic range proteinuria. She had a blunt renal trauma 4 weeks ago and was treated by the left main renal artery ligation.... -
- CITED
-
- Close
- SHARE
-
- Close
- Selection of Antihypertensive Drugs in Hypertensive Patients with Diabetes Mellitus: In Pohang-Gyeongju Primary Care Research Network
-
Jang CW, Ha KH, Sung NJ, Lee DW, Cho KR, Jung SH, Choi S, Ki JM, Kim SW, Choi KJ, Kim DI, Song JS, Choi YK, Song HN, Park KH
- KMID: 2182375
- J Korean Acad Fam Med.
- 2006 Sep;27(9):706-712.
BACKGROUND: Angiotensin converting enzyme inhibitor or Angiotensin II type 1 receptor blocker is usually recommended for hypertensive patients with diabetes mellitus. No reports have been made on antihypertensive agents prescribed... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative effects of angiotensin II and angiotensin-(4-8) on blood pressure and ANP secretion in rats
-
Phuong HT, Yu L, Park BM, Kim SH
- KMID: 2395262
- Korean J Physiol Pharmacol.
- 2017 Nov;21(6):667-674.
- doi: 10.4196/kjpp.2017.21.6.667
Angiotensin II (Ang II) is metabolized from N-terminal by aminopeptidases and from C-terminal by Ang converting enzyme (ACE) to generate several truncated angiotensin peptides (Angs). The truncated Angs have different... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension
-
Kim JH, Oh SJ, Lee JM, Hong EG, Yu JM, Han KA, Min KW, Son HS, Chang SA
- KMID: 2175425
- Diabetes Metab J.
- 2011 Jun;35(3):236-242.
- doi: 10.4093/dmj.2011.35.3.236
BACKGROUND: Hypertension and type 2 diabetes mellitus are major risk factors for cardiovascular disease. This study analyzed the changes in central aortic waveforms and pulse wave velocity as well as... -
- CITED
-
- Close
- SHARE
-
- Close
- Inducible Nitric Oxide Synthase (iNOS) is Increased in Diabetic Rat Glomeruli: Role of Angiotensin II (AII)
-
Choi KH, Noh H, Kim BS, Kang SW, Han DS, Lee HY
- KMID: 1610172
- Korean J Nephrol.
- 2003 Jul;22(4):366-373.
BACKGROUND: This study was designed to examine whether iNOS pathway is pathologically altered in experimental diabetic nephropathy and whether therapy with ACE inhibitor (imidapril: I) or angiotensin II type 1... -
- CITED
-
- Close
- SHARE
-
- Close
- Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients
-
Agachan B, Isbir T, Yilmaz H, Akoglu E
- KMID: 1119337
- Exp Mol Med.
- 2003 Dec;35(6):545-549.
Essential hypertension is a multifactorial disease in which genetic and enviromental factors play an important role. These factors differ in each population. As there are no existing data for the... -
- CITED
-
- Close
- SHARE
-
- Close
- Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway
-
Kim I, Park CS, Lee HY
- KMID: 2450393
- Korean Circ J.
- 2019 Jul;49(7):615-626.
- doi: 10.4070/kcj.2018.0379
BACKGROUND AND OBJECTIVES: Angiotensin II (Ang II) has been suggested to accelerate vascular senescence, however the molecular mechanism(s) remain unknown. METHODS: We cultured human coronary artery smooth muscle cells (hCSMCs) and... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential brain angiotensin-II type I receptor expression in hypertensive rats
-
Braga VA
- KMID: 1067403
- J Vet Sci.
- 2011 Sep;12(3):291-293.
- doi: 10.4142/jvs.2011.12.3.291
Blood-borne angiotensin-II (Ang-II) has profound effects in the brain. We tested the hypothesis that Ang-II-dependent hypertension involves differential Ang-II type I (AT1) receptors expression in the subfornical organ (SFO) and... -
- CITED
-
- Close
- SHARE
-
- Close
- Polymorphism of the Angiotensin II Type 1 Receptor A1166C in Korean Hypertensive Adolescents
-
Lee JA, Sohn JA, Hong YM
- KMID: 2225760
- Korean Circ J.
- 2008 Aug;38(8):405-410.
- doi: 10.4070/kcj.2008.38.8.405
BACKGROUND AND OBJECTIVES: The renin-angiotensin system (RAS) is a major regulator of blood pressure. The angiotensin II receptor type 1 (AGTR 1) A1166C has been extensively studied in searching for... -
- CITED
-
- Close
- SHARE
-
- Close
- Evolution and Regulation of Renal Renin and Transforming Growth Factor beta 1 Gene Expression in the Unilateral Ureteral Obstruction of the Neonatal Rat
-
Chung KH, Choi H
- KMID: 1914160
- Korean J Urol.
- 1996 May;37(5):493-504.
Unilateral ureteral obstruction(UUO) in early development impairs renal growth. To investigate the potential role of growth-related peptides in this response, Sprague-Dawley rats underwent UUO or sham operation in the first... -
- CITED
-
- Close
- SHARE
-
- Close
- Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection
-
Lee H, Kim JI, Moon IS, Chung BH, Yang CW, Kim Y, Han K, Oh EJ
- KMID: 2363203
- Ann Lab Med.
- 2015 May;35(3):314-320.
- doi: 10.3343/alm.2015.35.3.214
BACKGROUND: Angiotensin II type 1 receptor (AT1R) is responsible for cardiovascular effects mediated by angiotensin II. This study aimed to investigate the impact of antibodies directed against AT1R (anti-AT1R) in... -
- CITED
-
- Close
- SHARE
-
- Close
- A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats
-
Chang SA, Lim BK, Lee YJ, Hong MK, Choi JO, Jeon ES
- KMID: 2155468
- J Korean Med Sci.
- 2015 May;30(5):559-568.
- doi: 10.3346/jkms.2015.30.5.559
Angiotensin receptor blockers (ARBs) have organ-protective effects in heart failure and may be also effective in doxorubicin-induced cardiomyopathy (DOX-CMP); however, the efficacy of ARBs on the prevention of DOX-CMP have... -
- CITED
-
- Close
- SHARE
-
- Close
- 24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension
-
Lee HY, Kim CH, Song JK, Chae SC, Jeong MH, Kim DS, Oh BH
- KMID: 2396762
- Korean J Intern Med.
- 2017 Nov;32(6):1025-1036.
- doi: 10.3904/kjim.2016.094
BACKGROUND/AIMS: Fimasartan is an angiotensin type 1 receptor blocker (ARB) which has comparable efficacy and tolerability with other ARBs. The aim of this study was to evaluate 24-hour blood pressure... -
- CITED
-
- Close
- SHARE
-
- Close
- Angiotensinogen and Angiotensin II Type 1 Receptor Gene Polymorphism in Patients with Autosomal Dominant Polycystic Kidney Disease: Effect on Hypertension and ESRD
-
Lee KB, Kim UK
- KMID: 720904
- Yonsei Med J.
- 2003 Aug;44(4):641-647.
- doi: 10.3349/ymj.2003.44.4.641
Autosomal dominant polycystic kidney disease (ADPKD), a common genetic disease, is characterized by the development of hypertension and end stage renal disease. An increase in the activity of the renin-angiotensin... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients
-
Min JW, Lee H, Choi BS, Park CW, Yang CW, Kim YS, Choi YJ, Oh EJ, Chung BH
- KMID: 2434735
- Ann Lab Med.
- 2018 Sep;38(5):450-457.
- doi: 10.3343/alm.2018.38.5.450
BACKGROUND: Evidence of antibody-mediated injury in the absence of donor-specific HLA antibodies (HLA-DSA) has recently emerged, suggesting a role of antibodies in targeting non-HLA antigens expressed on renal allograft tissue.... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor necrosis factor α-converting enzyme inhibitor attenuates lipopolysaccharide-induced reactive oxygen species and mitogen-activated protein kinase expression in human renal proximal tubule epithelial cells
-
Bae EH, Kim IJ, Choi HS, Kim HY, Kim CS, Ma SK, Kim IS, Kim SW
- KMID: 2410103
- Korean J Physiol Pharmacol.
- 2018 Mar;22(2):135-143.
- doi: 10.4196/kjpp.2018.22.2.135
Tumor necrosis factor-α (TNFα) and the angiotensin system are involved in inflammatory diseases and may contribute to acute kidney injury. We investigated the mechanisms by which TNFα-converting enzyme (TACE) contributes... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Central Losartan on DOCA-Salt Hypertension Rats
-
Lee SJ, Park CG, Park JS, Kim EJ, Shin SH, Jin DG, Ahn JC, Seo HS, Oh DJ, Ro YM
- KMID: 1938858
- Korean Circ J.
- 2004 Jan;34(1):84-91.
- doi: 10.4070/kcj.2004.34.1.84
BACKGROUND: The purpose of this study was to investigate whether brain AT1 receptor stimulation contributes as a hypertensive mechanism to deoxycorticosterone acetate (DOCA)-salt hypertension. METHODS: 1) Acute injection:Losartan (1 mg/4... -
- CITED
-
- Close
- SHARE
-
- Close
